Ocular Therapeutix reports net loss of $28.7 million in 2014

Ocular Therapeutix reported a net loss of $28.7 million, or $2.69 per share, in 2014 compared with $13.3 million, or $5.11 per share, in 2013, according to a press release. Fourth quarter 2014 net loss totaled $8 million, or $0.37 per share, compared with $3.5 million, or $1.32 per share, in the same quarter in 2013.

Full Story →